Transsylvian selective amygdalohippocampectomy in children with hippocampal sclerosis: seizure, intellectual and

Anne E Beaton1, Andrew Durnford, Phillip E Heffer-Rahn

  • 1University Hospital Southampton, Southampton SO16 6YD, UK. anne.beaton@uhs.nhs.uk

Seizure
|August 18, 2012
PubMed

Insights

Transylvian selective amygdalohippocampectomy (TS SAH) effectively controls seizures in children with hippocampal sclerosis. Cognitive outcomes remained stable, with notable improvements in facial memory, challenging prior beliefs about TS SAH efficacy.

Area of Science:

  • Pediatric Neurosurgery
  • Epileptology
  • Cognitive Neuroscience

Background:

  • Medically intractable epilepsy in children often stems from unilateral hippocampal sclerosis.
  • Surgical interventions are considered when conservative treatments fail.
  • Transylvian selective amygdalohippocampectomy (TS SAH) is a specialized neurosurgical procedure.

Purpose of the Study:

  • To evaluate the efficacy of TS SAH in pediatric patients with hippocampal sclerosis.
  • To assess post-surgical seizure control and cognitive outcomes (intellectual and memory functions).

Main Methods:

  • Retrospective analysis of pre- and post-surgical data from 10 pediatric patients.
  • Follow-up period of 24 months post-TS SAH.
  • Comparison of seizure frequency, antiepileptic drug (AED) use, intellect, and memory before and after surgery.

Main Results:

  • High seizure freedom rates: 90% at 12 months and 87.5% at 24 months (Engel I classification).
  • No significant group-level decline in intellect or verbal/visual memory.
  • Significant improvement in immediate and delayed facial memory post-operatively.

Conclusions:

  • TS SAH demonstrates good post-surgical seizure control in children with hippocampal sclerosis.
  • Cognitive outcomes are generally favorable, with specific memory improvements.
  • Findings challenge previous notions regarding the ineffectiveness of SAH in pediatric epilepsy surgery.
Abstract